US Broker Ratings

Omnicell, Inc. (OMCL)

⚠️ No article content returned.

..

Supernus Pharmaceuticals, Inc. (SUPN) Investor Outlook: Potential Upside and Analyst Ratings Signal Growth Prospects

Supernus Pharmaceuticals, Inc. (SUPN) has emerged as a noteworthy player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Headquartered in Rockville, Maryland, this biopharmaceutical..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Capitalizing on a 155% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is garnering significant attention in the biotechnology sector, with its promising pipeline of novel oral small molecule therapeutics aimed at addressing chronic diseases with unmet..

Envista Holdings Corporation (NVST) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Ratings

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $3.38 billion, this..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 16.86% Potential Upside in Medical Devices

For investors with a keen eye on the healthcare sector, Alphatec Holdings, Inc. (NASDAQ: ATEC) presents an intriguing opportunity. Specializing in medical devices, particularly for spinal disorder treatments, Alphatec has..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with Growth Potential

Brookdale Senior Living Inc. (NYSE: BKD) sits at the intersection of healthcare and real estate, primarily serving the senior living sector in the United States. With a market capitalization of..

89bio, Inc. (ETNB) Stock Analysis: A Biotech Play with Nearly 98% Upside Potential

89bio, Inc. (NASDAQ: ETNB) continues to capture attention in the healthcare sector, specifically within the biotechnology industry. With its current market capitalization pegged at $2.2 billion, this clinical-stage biopharmaceutical company..

Sotera Health Company (SHC) Stock Analysis: Navigating Growth in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector as a key player in the diagnostics and research industry. With a market capitalization of $4.75 billion, the company..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 38% Potential Upside in the Medical Devices Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the medical devices sector, has captured the attention of investors with its innovative technology solutions for diabetes management. With a..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 48.65% Potential Upside in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This precision medicine oncology company, headquartered in South San Francisco, stands..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 64% Potential Upside in the Healthcare Sector

For investors eyeing the healthcare sector, UFP Technologies, Inc. (NASDAQ: UFPT) presents a compelling opportunity. With its focus on medical devices and a robust market cap of $1.54 billion, UFP..

Denali Therapeutics Inc. (DNLI) Stock Analysis: 94.94% Potential Upside Beckons Investors

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company headquartered in South San Francisco, California, has been capturing the attention of investors with its ambitious pipeline targeting neurodegenerative and lysosomal storage..

NovoCure Limited (NVCR) Stock Analysis: A Healthcare Innovator with Nearly 97% Potential Upside

For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with substantial growth potential. This Swiss-based company specializes in the development and commercialization of..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 31.51% Potential Upside Amidst Current Market Dynamics

For investors keeping a keen eye on opportunities in the healthcare sector, Neogen Corporation (NASDAQ: NEOG) presents a compelling case. As a prominent player in the diagnostics and research industry,..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring Solid Revenue Growth and Analyst Enthusiasm

GeneDx Holdings Corp. (WGS), a key player in the genomics sector, has been capturing the attention of investors with its remarkable 45.60% revenue growth. This impressive figure, combined with robust..

Merus N.V. (MRUS) Stock Analysis: Evaluating the 2.54% Upside Potential in Biotechnology’s Dynamic Landscape

Merus N.V. (MRUS), a Netherlands-based biotechnology company, stands out in the healthcare sector with a market capitalization of $7.17 billion. Specializing in the development of innovative antibody therapeutics, Merus is..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Complex Landscape with a 2.99% Dividend Yield

Premier, Inc. (NASDAQ: PINC) is a prominent player in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $2.32 billion, Premier is headquartered in..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: Unpacking a Potential 227% Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a dynamic player in the biotechnology sector, is currently making waves in the investment community with a potential upside of 227.75%. The company, headquartered in..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech with a 95% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its considerable potential in the biotechnology sector, evidenced by a striking 95.21% upside potential based on analyst price..

Indivior PLC (INDV) Stock Analysis: Promising 17.7% Upside Potential Amidst Rising Demand for Opioid Treatment Solutions

Indivior PLC (INDV), a major player in the healthcare sector, focuses on developing prescription medications for opioid dependence and related disorders. With a market capitalization of $3.09 billion, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds